Massivemarkets

LTGO

Latigo Biotherapeutics, Inc. Common Stock

Nasdaq · usd

$13.31-0.45 (-3.27%)
As of 5:19:44 PM EST on Nov 18, 2026 · 15-minute delayed

Latigo Biotherapeutics, Inc. Common Stock (LTGO) trades at $13.31 (-3.27%) as of 5:19:44 PM EST on Nov 18, 2026, -12.72% over the past month. Market cap is $882.44M, with 5.4 days to cover in short interest.

Stock performance

How Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock has performed from one day to one year, with its 52-week range.

-5.74%
-$0.81 over 1D
$13.32$13.60$13.88$14.179:30 AM11:10 AM12:35 PM2:50 PM8:00 PM$13.31
1D
-3.27%
1W
-1.55%
1M
-12.72%
YTD
-27.07%
1Y
-27.07%
52-wk range
$10.24 – $25.93

Key statistics

Today's trading snapshot for LTGO: day range, open, previous close, volume and market cap.

Day range
$13.21 – $14.26
Open
$14.00
Prev close
$13.76
Volume
209.1K
Market cap
$882.44M
Shares out
66.3M

8-K filings

Material corporate events Latigo Biotherapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On November 5, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • On September 3, 2026, Latigo Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.

  • Public offeringAug 10, 2026

    On August 10, 2026, the Company completed its IPO of an aggregate of 19,200,000 shares of common stock at a price to the public of $18.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $345.6 million.

LTGO short interest

How heavily LTGO is shorted: shares short, days to cover and average daily volume.

Days to cover
5.4
Short interest
941.43K
Avg volume
173.41K

As of · reported to FINRA twice monthly.

Frequently asked questions

What is the Latigo Biotherapeutics, Inc. Common Stock (LTGO) stock price today?

Latigo Biotherapeutics, Inc. Common Stock (LTGO) is trading at $13.31 (-3.27% on the day) as of 5:19:44 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Latigo Biotherapeutics, Inc. Common Stock?

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction.

What is the short interest in LTGO?

As of Oct 30, 2026, LTGO has 941.43K shares short and 5.4 days to cover.

What exchange is LTGO listed on?

Latigo Biotherapeutics, Inc. Common Stock (LTGO) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of LTGO with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LTGO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.